$0.34
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.
Milestone Scientific Inc. in the Healthcare sector is trading at $0.34 with a market capitalization of $39M. Wall Street consensus targets $1.25 (2 analysts), implying a +267.6% move over the next 12 months. The stock is currently 41% below its 52-week high of $0.58, remaining 2.9% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.84Mβ | $2.16Mβ | $2.06Mβ | $2.36Mβ | $2.32M |
| Gross Profit | $1.91Mβ | $1.56Mβ | $1.50Mβ | $1.64Mβ | $1.62M |
| Operating Income | -$1.06Mβ | -$828,083β | -$1.08Mβ | -$1.13Mβ | -$1.48M |
| Net Income | -$1.06Mβ | -$839,853β | -$1.09Mβ | -$1.15Mβ | -$1.48M |
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It ...